Histology
Non-Small Cell Carcinoma
CI-CAN-00001292Explore in graph →
1,752 active trials47 approved drugs589 evidence items
- NCIt
- C65151
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00001292Explore in graph →
Clinical trials
6,757 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,046)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03736993 | Metabolomics Predict Therapy Response(PROLUNG) | completed | N/A | 160 | Hasselt UniversityOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT05689619 | SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)(SILMET) | recruiting | N/A | 70 | A.O.U. Città della Salute e della ScienzaOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT05730972 | TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer | unknown | N/A | 188 | The Third Affiliated hospital of Zhejiang Chinese Medical UniversityOTHER | 0 | Dec 13, 2023 | clinicaltrials |
| NCT06165874 | [68Ga]Ga-NOTA-RW102 PET Imaging in the Diagnosis of PD-L1-expressing Lung Cancer | unknown | N/A | 20 | Huashan HospitalOTHER | 1 | Dec 12, 2023 | clinicaltrials |
| NCT02871856 | International Lung Screen Trial (ILST)(ILST) | unknown | N/A | 2,000 | The University of QueenslandOTHER | 2 | Dec 5, 2023 | clinicaltrials |
| NCT02949076 | Skeletal Muscle Atrophy and Dysfunction in Human Cancer | completed | N/A | 11 | University of VermontOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT05291403 | Efficacy and Safety Study of Medical Thoracoscope Cryotherapy Combined Standard First-line Treatment of Advanced Non-small Cell Lung Cancer and Malignant Pleural Effusion | unknown | N/A | 141 | Qianfoshan HospitalOTHER | 1 | Nov 18, 2023 | clinicaltrials |
| NCT04229381 | Resiliency Among Older Adults Receiving Lung Cancer Treatment(ROAR-LCT) | completed | N/A | 18 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 15, 2023 | clinicaltrials |
| NCT06127329 | Efficacy and Safety of BAI Combined With DEB-BACE of EqualSpheres in the Treatment of Advanced NSCLC | not yet recruiting | N/A | 70 | Gang WuOTHER | 1 | Nov 13, 2023 | clinicaltrials |
| NCT01401907 | Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies | completed | N/A | 351 | Massachusetts General HospitalOTHER | 1 | Oct 19, 2023 | clinicaltrials |
| NCT04040244 | Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis | terminated | N/A | 16 | Wake Forest University Health SciencesOTHER | 1 | Oct 11, 2023 | clinicaltrials |
| NCT04082988 | Early Response Evaluation in NSCLC Patients Treated With Immunotherapy | terminated | N/A | 9 | The Netherlands Cancer InstituteOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT04148066 | ctDNA Guided Treatment of Early Resistance to Targeted Treatment(TATIN) | completed | N/A | 104 | The Netherlands Cancer InstituteOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT04737382 | Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.(OSIRIS) | unknown | N/A | 200 | The Netherlands Cancer InstituteOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT05724004 | Alectinib Followed by Concomitant Consolidation Radiation Therapy in Advanced NSCLC With ALK-rearrangement (A-SAB)(A-SAB) | recruiting | N/A | 70 | Karolinska University HospitalOTHER | 1 | Oct 10, 2023 | clinicaltrials |
| NCT06056115 | Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic | recruiting | N/A | 20 | Hebei Medical University Fourth HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT03010657 | Modifying Your Diet to Support Muscle During Cancer Treatment. | completed | N/A | 37 | University of AlbertaOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT05999214 | 99mTc-H7ND SPECT/CT Imaging in NSCLC | unknown | N/A | 150 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Sep 25, 2023 | clinicaltrials |
| NCT03742687 | Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC | recruiting | N/A | 151 | Danish Lung Cancer GroupOTHER | 1 | Sep 11, 2023 | clinicaltrials |
| NCT06014450 | Prophylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical Study | unknown | N/A | 144 | Guizhou Medical UniversityOTHER | 1 | Aug 28, 2023 | clinicaltrials |
| NCT05998993 | Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO)(CULTRO) | not yet recruiting | N/A | 35 | Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento AnguloOTHER | 1 | Aug 21, 2023 | clinicaltrials |
| NCT04705025 | Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer(BNT001) | terminated | N/A | 5 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT03786003 | ELobectomy for NSCLC by VATS Versus Thoracotomy (ECTOP-1007) | recruiting | N/A | 1,086 | Fudan UniversityOTHER | 1 | Jul 21, 2023 | clinicaltrials |
| NCT05603299 | Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test | withdrawn | N/A | 0 | Qure Healthcare, LLCINDUSTRY | 0 | Jun 15, 2023 | clinicaltrials |
| NCT05527808 | A Single-arm Exploratory Study of Neoadjuvant Therapy | unknown | N/A | 28 | Jun LiuOTHER | 1 | Jun 8, 2023 | clinicaltrials |
| NCT05306652 | Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment(EXcellenT) | unknown | N/A | 40 | AUSL Romagna RiminiOTHER | 1 | May 31, 2023 | clinicaltrials |
| NCT05014035 | Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer | completed | N/A | 14 | University of South CarolinaOTHER | 1 | May 12, 2023 | clinicaltrials |
| NCT05778708 | Tai-Chi and Aerobic Exercise to Improve Emotional Symptom Cluster in Late-stage Lung Cancer Patients | recruiting | N/A | 318 | The University of Hong KongOTHER | 1 | May 10, 2023 | clinicaltrials |
| NCT02805530 | Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma | completed | N/A | 36 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT04748523 | Effect of Mirtazapine Versus Placebo in Patients With Non-small Cell Lung Cancer and Anorexia | completed | N/A | 86 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05815472 | Advanced Patient Monitoring and A.I. Supported Outcomes Assessment in Lung Cancer Using Internet of Things Technologies (A.I. - APALITT)(APALITT) | unknown | N/A | 50 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT03908671 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer | unknown | N/A | 24 | Stemirna TherapeuticsINDUSTRY | 1 | Apr 13, 2023 | clinicaltrials |
| NCT02758054 | Patient Navigation for Lung Cancer Screening in an Urban Safety-Net System | completed | N/A | 447 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT02035683 | PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy(PETRA) | unknown | N/A | 220 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT02456246 | Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT(SBRT FLT-PET) | completed | N/A | 45 | University Health Network, TorontoOTHER | 1 | Mar 22, 2023 | clinicaltrials |
| NCT05620199 | Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy(UPLAN-I) | unknown | N/A | 20 | The Netherlands Cancer InstituteOTHER | 0 | Mar 20, 2023 | clinicaltrials |
| NCT01840150 | Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer | completed | N/A | 41 | Fox Chase Cancer CenterOTHER | 1 | Mar 13, 2023 | clinicaltrials |
| NCT02136355 | A Phase II Trial Measuring the Integration of Stereotactic Radiotherapy Plus Surgery in Early Non-Small Cell Lung Cancer | completed | N/A | 40 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT04159025 | EBUS-Miniforceps Biopsy Specimen Acquisition for PD-L1 Testing in Nonsmall Cell Lung Cancer | completed | N/A | 20 | Washington University School of MedicineOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT03707925 | Bronchoscopic Laser Ablation of Peripheral Lung Tumors | terminated | N/A | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05698264 | A Pilot Study to Understand the Impact of Therapy With Tumour Treating Fields (TTFields) in NSCLC | not yet recruiting | N/A | 50 | Nir PeledOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04941365 | Quantifying Systemic Immunosuppression to Personalize Cancer Therapy(SERPENTINE) | withdrawn | N/A | 0 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 0 | Dec 22, 2022 | clinicaltrials |
| NCT04436406 | PD-L1 Expression in Cancer (PECan Study).(PECan) | unknown | N/A | 30 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Dec 15, 2022 | clinicaltrials |
| NCT04758481 | Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer | unknown | N/A | 20 | University Hospital OstravaOTHER | 1 | Dec 7, 2022 | clinicaltrials |
| NCT04720339 | Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy. | recruiting | N/A | 250 | University Hospital, Strasbourg, FranceOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT05611450 | Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy | unknown | N/A | 108 | Chang Gung Memorial HospitalOTHER | 0 | Nov 10, 2022 | clinicaltrials |
| NCT02728596 | S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)(TrACER) | completed | N/A | 3,665 | SWOG Cancer Research NetworkNETWORK | 2 | Oct 20, 2022 | clinicaltrials |
| NCT05583409 | SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC | unknown | N/A | 72 | Li ZhangOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT05577052 | SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases | unknown | N/A | 100 | Wuhan UniversityOTHER | 0 | Oct 13, 2022 | clinicaltrials |
| NCT01860898 | A Phase I Study of iPS Cell Generation From Patients With COPD | completed | N/A | 31 | Mayo ClinicOTHER | 1 | Sep 28, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Dec 15, 2023source: clinicaltrials